Bionano Genomics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Bionano Genomics, Inc. reported its Q1 2026 earnings, revealing a loss per share of $0.75, which was better than analysts' expectations. The company also reported revenue of $6.69 million, marking a year-over-year increase of 3.56%. This earnings call presentation highlights the company's financial performance and outlook.
- ▪Bionano Genomics, Inc. reported an EPS of -$0.75, beating estimates by $0.20.
- ▪The company's revenue for Q1 2026 was $6.69 million, exceeding expectations by $119.50K.
- ▪This presentation was published in conjunction with their earnings call.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4905720-bionano-genomics-inc-2026-q1-results-earnings-call-presentation"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
